EPAM Systems
EPAM
$110.34
+3.35%
EPAM Systems is a global IT services firm specializing in platform engineering, software development, and consulting, operating within the Information Technology Services industry. The company is a market leader in engineering-centric digital transformation, known for its deep technical expertise and delivery capabilities across North America, which accounts for approximately 60% of its revenue. Currently, EPAM is navigating a period of strategic recalibration, as investors debate the impact of AI disruption on its traditional delivery model, while management guides for modest growth in 2026 after a year of revenue acceleration. Recent headlines highlight a stock crash following Q4 earnings, driven by concerns over weak GAAP profitability and slowing organic growth, despite an earnings beat and optimistic guidance.…
EPAM
EPAM Systems
$110.34
Related headlines
Investment Opinion: Should I buy EPAM Today?
Rating: Hold. EPAM is a high-risk, high-reward opportunity with a consensus 'buy' rating and an average target price of $122.82, implying 11.3% upside. The thesis is that the stock is undervalued on forward earnings, but the market is pricing in significant AI disruption risk. Investors should wait for evidence of margin stabilization before committing.
Sign up to view all
EPAM 12-Month Price Forecast
EPAM is at a crossroads where AI is both a threat and an opportunity. The market has priced in significant pessimism, as evidenced by the low forward P/E, but the company's strong balance sheet and accelerating revenue growth provide a foundation. The neutral stance reflects the balanced risk-reward; I would upgrade to bullish if margins stabilize and AI investments start yielding revenue, and downgrade to bearish if revenue growth decelerates below 5% or margins deteriorate further.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on EPAM Systems's 12-month outlook, with a consensus price target around $122.82 and implied upside of +11.3% versus the current price.
Average Target
$122.82
0 analysts
Implied Upside
+11.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$94 - $200
Analyst target range
EPAM is covered by 17 analysts, with a consensus recommendation of 'buy' and a mean recommendation score of 2.11 (where 1 is strong buy and 5 is sell). The average target price is $122.82, implying an upside of 11.3% from the current price of $110.34. The distribution of ratings is not explicitly provided, but the 'buy' consensus and recent actions from firms like Wells Fargo (Overweight), TD Cowen (Buy), and Needham (Buy) indicate a bullish tilt, though some firms like Jefferies downgraded to Hold and Goldman Sachs moved to Neutral, reflecting mixed sentiment. The target price range spans from a low of $94.00 to a high of $200.00, with the high target implying an 81.2% upside, likely assuming a successful AI transformation and margin expansion, while the low target suggests a 14.8% downside, possibly pricing in continued margin pressure and competitive losses. The wide spread between low and high targets (106 points) indicates high uncertainty about EPAM's future, as analysts are divided on the impact of AI on the company's business model. Recent institutional ratings show a mix of actions, with some firms maintaining positive stances and others downgrading, reflecting the ongoing debate about EPAM's growth trajectory and profitability.
Bulls vs Bears: EPAM Investment Factors
EPAM presents a classic value-versus-value-trap debate. The bull case rests on accelerating revenue growth, a deeply discounted forward P/E, and a fortress balance sheet, while the bear case highlights margin compression, AI disruption risk, and a stock in a severe downtrend. Currently, the bearish evidence is stronger given the 33.7% one-year decline and deteriorating profitability, but the forward P/E of 7.85x suggests the market has already priced in significant pessimism. The single most important tension is whether EPAM can successfully navigate AI disruption to restore margin expansion and sustain growth; if it does, the stock is deeply undervalued, but if not, the low forward P/E could be a trap.
Bullish
- Revenue growth accelerating: Q1 2026 revenue grew 7.56% YoY to $1.400B, up from -1.6% in Q2 2024, showing a clear recovery trend. Sequential growth from Q2 2025 ($1.354B) to Q1 2026 ($1.400B) indicates momentum.
- Forward P/E deeply discounted: Forward P/E of 7.85x is a 64% discount to the industry average of 22x, implying the market expects a massive earnings recovery. With estimated 2026 EPS of $15.17, the stock trades at a fraction of its growth potential.
- Strong balance sheet: Debt-to-equity of 0.039 and current ratio of 2.59 provide ample liquidity and financial flexibility. TTM free cash flow of $543.6M supports investments in AI and buybacks.
- Analyst consensus bullish: 17 analysts rate EPAM a 'buy' with a mean score of 2.11, and the average target price of $122.82 implies 11.3% upside. Recent upgrades from Wells Fargo and TD Cowen reinforce positive sentiment.
Bearish
- Stock down 33.7% in 1 year: EPAM underperformed the S&P 500 by 54.2 percentage points over the past year, reflecting severe investor pessimism. The stock trades at 25.5% of its 52-week range, near the low.
- Margin compression persists: Gross margin fell to 25.59% in Q1 2026 from 30.07% in Q4 2025, and operating margin dropped to 8.47% from 10.60%. This indicates rising delivery costs and AI investments are pressuring profitability.
- Weak GAAP profitability: Net margin of 5.89% in Q1 2026 is down from 7.77% in Q4 2025, and Q1 operating cash flow was negative at -$36.4M due to working capital swings. This raises concerns about earnings quality.
- AI disruption threat: The stock crash after Q4 earnings was driven by fears that AI will disrupt EPAM's traditional delivery model. The company's low forward P/E may reflect skepticism about sustainable growth.
EPAM Technical Analysis
EPAM's stock is in a pronounced downtrend over the past year, with a 1-year price change of -33.69%, significantly underperforming the S&P 500's +20.48% gain. The current price of $110.34 sits at 25.5% of its 52-week range (between $73.06 low and $222.53 high), indicating the stock is trading near the lower end of its annual range, which typically suggests a value opportunity or a falling knife, depending on fundamental support. The stock has been in a recovery mode since hitting a 52-week low of $73.06 in June 2026, but it remains far below its 52-week high of $222.53, reflecting a severe bear market.
Beta
1.37
1.37x market volatility
Max Drawdown
-65.7%
Largest decline past year
52-Week Range
$73-$223
Price range past year
Annual Return
-33.7%
Cumulative gain past year
| Period | EPAM Return | S&P 500 |
|---|---|---|
| 1m | +27.5% | +3.6% |
| 3m | +7.4% | +2.7% |
| 6m | -20.5% | +11.4% |
| 1y | -33.7% | +18.7% |
| ytd | -45.0% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EPAM Fundamental Analysis
EPAM's revenue trajectory shows a recovery, with Q1 2026 revenue of $1.400 billion, up 7.56% YoY from $1.302 billion in Q1 2025, and sequentially up from $1.354 billion in Q2 2025. The multi-quarter trend indicates accelerating growth, as revenue grew from $1.147 billion in Q2 2024 to $1.400 billion in Q1 2026, with YoY growth rates improving from -1.6% in Q2 2024 to +7.56% in Q1 2026. Segment data shows Financial Services is the largest vertical at $350.2 million, followed by Consumer Goods, Retail & Travel at $273.9 million, and Software & Hi-Tech at $210.7 million, with all segments contributing to growth. The company's profitability is solid, with Q1 2026 net income of $82.5 million and a net margin of 5.89%, though this is down from the 7.77% net margin in Q4 2025, reflecting seasonal and investment impacts. Gross margin in Q1 2026 was 25.59%, down from 30.07% in Q4 2025, indicating margin compression due to higher delivery costs and investments in AI capabilities. Operating margin also declined to 8.47% in Q1 2026 from 10.60% in Q4 2025, but the company remains profitable with a trailing twelve-month free cash flow of $543.6 million. EPAM's balance sheet is conservative, with a debt-to-equity ratio of 0.039, indicating minimal leverage, and a current ratio of 2.59, providing ample liquidity. The company generated $543.6 million in TTM free cash flow, but Q1 2026 saw negative operating cash flow of -$36.4 million due to working capital changes, including a $78.8 million increase in accounts receivable and a $138.0 million change in working capital, which is a temporary seasonal pattern. ROE stands at 10.27%, and ROA at 8.45%, reflecting efficient use of equity and assets, though the negative FCF in Q1 highlights the need to monitor cash conversion.
Quarterly Revenue
$1.4B
2026-03
Revenue YoY Growth
+7.6%
YoY Comparison
Gross Margin
25.6%
Latest Quarter
Free Cash Flow
$543641000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EPAM Overvalued?
Given that EPAM is profitable with a positive net income of $82.5 million in Q1 2026, the primary valuation metric selected is the P/E ratio. The trailing P/E is 30.31x, while the forward P/E is 7.85x, a significant gap that implies the market expects a substantial earnings increase in the next year, likely driven by the estimated EPS of $15.17 for 2026. This forward P/E of 7.85x is extremely low, suggesting the market is pricing in a sharp earnings recovery, but it may also reflect skepticism about the sustainability of current earnings. Compared to the industry average P/E of 22x (from valuation data), EPAM's trailing P/E of 30.31x represents a 38% premium, but its forward P/E of 7.85x is a 64% discount, indicating that on a forward basis, the stock is undervalued relative to peers, which could be justified by its lower growth prospects or higher risk. Historically, EPAM's trailing P/E has ranged from 22.12x in Q1 2026 to 66.58x in Q4 2021, with the current 30.31x sitting below the midpoint of that range, suggesting the stock is not at extreme valuation levels. The PS ratio of 2.10x is well below its historical average of around 10x, indicating the stock is trading at a significant discount to its own historical sales multiple, which could signal a value opportunity or reflect deteriorating growth expectations.
PE
30.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 20x~70x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are prominent: EPAM's gross margin fell from 30.07% in Q4 2025 to 25.59% in Q1 2026, and operating margin dropped to 8.47%, indicating cost pressures from AI investments and delivery. Q1 2026 operating cash flow was negative at -$36.4M due to a $78.8M increase in accounts receivable, though TTM FCF remains positive at $543.6M. The company's net margin of 5.89% is thin, and any further deterioration could pressure earnings. However, the balance sheet is conservative with a debt-to-equity of 0.039 and current ratio of 2.59, providing a cushion against operational shocks.
FAQ
The key risks are: 1) AI disruption, which could erode EPAM's competitive advantage and lead to client losses; 2) Margin compression, as gross margin fell from 30.07% to 25.59% in one quarter, indicating cost pressures; 3) Macro sensitivity, given the beta of 1.37 and the stock's underperformance relative to the S&P 500; and 4) Execution risk on the AI transformation, which could fail to deliver expected returns. The most severe risk is a combination of AI disruption and margin compression, which could drive the stock to the 52-week low of $73.06, a -33.8% downside.
The 12-month forecast is mixed: the base case (50% probability) sees the stock trading around $110-$135, near the analyst average target of $122.82, assuming revenue growth of 7-8% and stable margins. The bull case (25% probability) targets $150-$200, driven by successful AI integration and margin expansion. The bear case (25% probability) targets $73-$94, if AI disruption and margin compression worsen. The most likely scenario is the base case, with the stock remaining range-bound as the market awaits clarity on AI's impact.
EPAM is undervalued on forward earnings, with a forward P/E of 7.85x versus the industry average of 22x, a 64% discount. However, on trailing earnings, the P/E of 30.31x is a 38% premium to peers, reflecting the market's skepticism about future earnings. The PS ratio of 2.10x is well below its historical average of ~10x, suggesting the market is pricing in lower growth. Overall, the stock is undervalued if the company can achieve the estimated EPS of $15.17 for 2026, but the wide gap between trailing and forward P/E indicates high uncertainty.
EPAM is a good buy for investors with a high risk tolerance and a long-term horizon, given its forward P/E of 7.85x and analyst average target of $122.82, implying 11.3% upside. However, the stock has been in a severe downtrend, down 33.7% over the past year, and faces margin compression and AI disruption risks. The risk-reward is attractive if you believe in the AI transformation, but it's not a safe bet. Consider waiting for signs of margin stabilization or a further price drop below $90 to improve the margin of safety.
EPAM is more suitable for long-term investment (3-5 years) given its growth stage and the ongoing AI transformation. The stock is highly volatile (beta 1.37) and has been in a downtrend, making short-term trading risky. The company's revenue growth is accelerating, and the forward P/E is deeply discounted, but the margin compression and AI disruption risk require patience. A minimum holding period of 2-3 years is recommended to allow the AI strategy to play out and margins to recover. Short-term traders might find opportunities in the wide price swings, but the risk is high.